Medicine, ISSN 0025-7974, 08/2018, Volume 97, Issue 31, p. e11750
Objective The results of published studies which examined the association between variable number tandem repeat (VNTR) polymorphism of interleukin-1 receptor...
SUBTYPE | POPULATION | MEDICINE, GENERAL & INTERNAL | NUMBER TANDEM REPEATS | IL-1 | SUSCEPTIBILITY | DISEASE | meta-analysis | variable number tandem repeat | INTRON-2 POLYMORPHISM | interleukin-1 receptor antagonist | ischemic stroke | Asian Continental Ancestry Group | Genetic Predisposition to Disease | Humans | Brain Ischemia - genetics | Interleukin 1 Receptor Antagonist Protein - genetics | Odds Ratio | Stroke - genetics | Minisatellite Repeats | Polymorphism, Genetic | Stroke (Disease) | Care and treatment | Cell receptors | Interleukins | Development and progression | Genetic aspects | Health aspects | Genetic polymorphisms
SUBTYPE | POPULATION | MEDICINE, GENERAL & INTERNAL | NUMBER TANDEM REPEATS | IL-1 | SUSCEPTIBILITY | DISEASE | meta-analysis | variable number tandem repeat | INTRON-2 POLYMORPHISM | interleukin-1 receptor antagonist | ischemic stroke | Asian Continental Ancestry Group | Genetic Predisposition to Disease | Humans | Brain Ischemia - genetics | Interleukin 1 Receptor Antagonist Protein - genetics | Odds Ratio | Stroke - genetics | Minisatellite Repeats | Polymorphism, Genetic | Stroke (Disease) | Care and treatment | Cell receptors | Interleukins | Development and progression | Genetic aspects | Health aspects | Genetic polymorphisms
Journal Article
Pediatric Pulmonology, ISSN 8755-6863, 09/2018, Volume 53, Issue 9, pp. 1276 - 1283
Background High morbidity and mortality due to community‐acquired pneumonia (CAP) is seen in children under 5 years of age in India. Besides identified risk...
IL1RA serum levels | community‐acquired pneumonia | children | Interleukin 1 receptor antagonist (IL1 RA) gene polymorphisms | India | community-acquired pneumonia | MORTALITY | INFECTIONS | IL-1RA | SEPSIS | CYTOKINE PRODUCTION | PLASMA-LEVELS | RESPIRATORY SYSTEM | SEPTIC SHOCK | PEDIATRICS | IL-1-BETA | INTRON-2 | Genes | Septic shock | Congenital heart disease | Genetic aspects | Children | Enzyme-linked immunosorbent assay | Genetic polymorphisms
IL1RA serum levels | community‐acquired pneumonia | children | Interleukin 1 receptor antagonist (IL1 RA) gene polymorphisms | India | community-acquired pneumonia | MORTALITY | INFECTIONS | IL-1RA | SEPSIS | CYTOKINE PRODUCTION | PLASMA-LEVELS | RESPIRATORY SYSTEM | SEPTIC SHOCK | PEDIATRICS | IL-1-BETA | INTRON-2 | Genes | Septic shock | Congenital heart disease | Genetic aspects | Children | Enzyme-linked immunosorbent assay | Genetic polymorphisms
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 1/2002, Volume 34, Issue 2, pp. 204 - 209
Interleukin-1 receptor antagonist (IL-1RA) is a naturally occurring competitive inhibitor of interleukin-1 (IL-1)-induced proinflammatory activity. The IL-1RA...
Homozygotes | Receptors | Immune response | Cytokines | Review Article | Genes | Alleles | Bones | Autoimmune diseases | Coronary artery disease | Genotypes | RHEUMATOID-ARTHRITIS | INFECTIOUS DISEASES | IL-1RA | RHESUS-MONKEYS | ULCERATIVE-COLITIS | MICROBIOLOGY | INTRAAMNIOTIC INFECTION | IMMUNOLOGY | WOMEN | BONE LOSS | IL-1-BETA | INFLAMMATORY BOWEL-DISEASE | ASSOCIATION | Sialoglycoproteins - genetics | Genetic Predisposition to Disease | Animals | Humans | Interleukin 1 Receptor Antagonist Protein | Polymorphism, Genetic - genetics | Receptors, Interleukin-1 - antagonists & inhibitors | Physiological aspects | Interleukin-1 | Care and treatment | Genetic disorders
Homozygotes | Receptors | Immune response | Cytokines | Review Article | Genes | Alleles | Bones | Autoimmune diseases | Coronary artery disease | Genotypes | RHEUMATOID-ARTHRITIS | INFECTIOUS DISEASES | IL-1RA | RHESUS-MONKEYS | ULCERATIVE-COLITIS | MICROBIOLOGY | INTRAAMNIOTIC INFECTION | IMMUNOLOGY | WOMEN | BONE LOSS | IL-1-BETA | INFLAMMATORY BOWEL-DISEASE | ASSOCIATION | Sialoglycoproteins - genetics | Genetic Predisposition to Disease | Animals | Humans | Interleukin 1 Receptor Antagonist Protein | Polymorphism, Genetic - genetics | Receptors, Interleukin-1 - antagonists & inhibitors | Physiological aspects | Interleukin-1 | Care and treatment | Genetic disorders
Journal Article
Osteoarthritis and Cartilage, ISSN 1063-4584, 2013, Volume 21, Issue 7, pp. 930 - 938
Summary Objective Within the interleukin-1 (IL-1) cytokine family, IL-1 receptor antagonist ( IL1RN ) gene variants have been associated with radiological...
Rheumatology | Progression | Genetics | Interleukin-1 | Osteoarthritis | Population stratification | Predictive biomarker | C-REACTIVE PROTEIN | UNITED-STATES | HAPLOTYPES | PREVALENCE | RHEUMATOLOGY | RHEUMATIC CONDITIONS | POLYMORPHISMS | IL1R1 GENE | SUSCEPTIBILITY LOCUS | LINKAGE | ORTHOPEDICS | ASSOCIATION | Body Mass Index | Follow-Up Studies | Humans | Middle Aged | Risk Factors | Interleukin 1 Receptor Antagonist Protein - genetics | Male | Osteoarthritis, Knee - diagnostic imaging | Radiography | Haplotypes - genetics | Osteoarthritis, Knee - genetics | Aged, 80 and over | Polymorphism, Single Nucleotide - genetics | Adult | Female | Aged | Genetic research | Interleukins | Genes | population stratification | progression | genetics | predictive biomarker | osteoarthritis
Rheumatology | Progression | Genetics | Interleukin-1 | Osteoarthritis | Population stratification | Predictive biomarker | C-REACTIVE PROTEIN | UNITED-STATES | HAPLOTYPES | PREVALENCE | RHEUMATOLOGY | RHEUMATIC CONDITIONS | POLYMORPHISMS | IL1R1 GENE | SUSCEPTIBILITY LOCUS | LINKAGE | ORTHOPEDICS | ASSOCIATION | Body Mass Index | Follow-Up Studies | Humans | Middle Aged | Risk Factors | Interleukin 1 Receptor Antagonist Protein - genetics | Male | Osteoarthritis, Knee - diagnostic imaging | Radiography | Haplotypes - genetics | Osteoarthritis, Knee - genetics | Aged, 80 and over | Polymorphism, Single Nucleotide - genetics | Adult | Female | Aged | Genetic research | Interleukins | Genes | population stratification | progression | genetics | predictive biomarker | osteoarthritis
Journal Article
Immunologic Research, ISSN 0257-277X, 2/2019, Volume 67, Issue 1, pp. 151 - 156
Colorectal cancer (CRC) is one of the most common malignancies worldwide. Genetic variations in cytokine genes and their receptors lead to the severity of the...
Allergology | IL1RN | Immunology | Medicine & Public Health | Cytokines | Colorectal cancer | VNTR polymorphism | IL-4 | Internal Medicine | Medicine/Public Health, general | CARCINOGENESIS | INCREASED RISK | IMMUNOLOGY | ASSOCIATION | EPIDEMIOLOGY | Interleukins | Liver | Oncology, Experimental | Genes | Genetic research | Genetic aspects | Disease susceptibility | Research | Genetic polymorphisms | Cancer | Liver diseases | Interleukin 1 receptor antagonist | Interleukin | Colorectal carcinoma | Population studies | Genetic diversity | Inflammation | Gene polymorphism | Receptors | Interleukin 4 | Genotyping | Interleukin 1 | Genotypes | Deoxyribonucleic acid--DNA | Salting | Polymorphism
Allergology | IL1RN | Immunology | Medicine & Public Health | Cytokines | Colorectal cancer | VNTR polymorphism | IL-4 | Internal Medicine | Medicine/Public Health, general | CARCINOGENESIS | INCREASED RISK | IMMUNOLOGY | ASSOCIATION | EPIDEMIOLOGY | Interleukins | Liver | Oncology, Experimental | Genes | Genetic research | Genetic aspects | Disease susceptibility | Research | Genetic polymorphisms | Cancer | Liver diseases | Interleukin 1 receptor antagonist | Interleukin | Colorectal carcinoma | Population studies | Genetic diversity | Inflammation | Gene polymorphism | Receptors | Interleukin 4 | Genotyping | Interleukin 1 | Genotypes | Deoxyribonucleic acid--DNA | Salting | Polymorphism
Journal Article
PLoS ONE, ISSN 1932-6203, 09/2012, Volume 7, Issue 9, p. e46017
IL1 receptor antagonist (IL1RA) and IL1beta (IL1 beta), members of the pro-inflammatory cytokine interleukin-1 (IL1) family, play a potential role against...
BREAST-CANCER | IL-1RN POLYMORPHISMS | LUNG-CANCER | GASTRIC-CANCER | INTERLEUKIN-1-BETA GENE | MULTIDISCIPLINARY SCIENCES | CERVICAL-CANCER | HELICOBACTER-PYLORI | HEPATITIS-C | CARCINOMA | CHINESE POPULATION | Stomach Neoplasms - genetics | Interleukin-1 - genetics | Genetic Predisposition to Disease | Humans | Stomach Neoplasms - metabolism | Genotype | Interleukin 1 Receptor Antagonist Protein - genetics | Risk | Interleukin 1 Receptor Antagonist Protein - physiology | Interleukin-1beta - genetics | Models, Statistical | Case-Control Studies | Minisatellite Repeats | Polymorphism, Genetic | Neoplasms - genetics | Interleukin-1beta - metabolism | Models, Genetic | Odds Ratio | Cytokines | Physiological aspects | Development and progression | Genetic aspects | Research | Risk factors | Genetic polymorphisms | Cancer | Pathogenesis | Interleukin | Bladder | Infections | Gene polymorphism | Epidemiology | Stomach cancer | Proteins | Literature reviews | Confidence intervals | Liver cancer | Hepatitis | Urinary bladder | Mathematical analysis | Etiology | Rodents | Interleukin 1 | Gastric cancer | Genotypes | Interleukin 1 receptor antagonist | Health risks | Breast cancer | Inflammation | Gene expression | Meta-analysis | Medicine | Studies | Ethnicity | Hospitals | Binding sites | Polymorphism
BREAST-CANCER | IL-1RN POLYMORPHISMS | LUNG-CANCER | GASTRIC-CANCER | INTERLEUKIN-1-BETA GENE | MULTIDISCIPLINARY SCIENCES | CERVICAL-CANCER | HELICOBACTER-PYLORI | HEPATITIS-C | CARCINOMA | CHINESE POPULATION | Stomach Neoplasms - genetics | Interleukin-1 - genetics | Genetic Predisposition to Disease | Humans | Stomach Neoplasms - metabolism | Genotype | Interleukin 1 Receptor Antagonist Protein - genetics | Risk | Interleukin 1 Receptor Antagonist Protein - physiology | Interleukin-1beta - genetics | Models, Statistical | Case-Control Studies | Minisatellite Repeats | Polymorphism, Genetic | Neoplasms - genetics | Interleukin-1beta - metabolism | Models, Genetic | Odds Ratio | Cytokines | Physiological aspects | Development and progression | Genetic aspects | Research | Risk factors | Genetic polymorphisms | Cancer | Pathogenesis | Interleukin | Bladder | Infections | Gene polymorphism | Epidemiology | Stomach cancer | Proteins | Literature reviews | Confidence intervals | Liver cancer | Hepatitis | Urinary bladder | Mathematical analysis | Etiology | Rodents | Interleukin 1 | Gastric cancer | Genotypes | Interleukin 1 receptor antagonist | Health risks | Breast cancer | Inflammation | Gene expression | Meta-analysis | Medicine | Studies | Ethnicity | Hospitals | Binding sites | Polymorphism
Journal Article
Biomaterials, ISSN 0142-9612, 2012, Volume 33, Issue 27, pp. 6520 - 6532
Abstract Cytoxicity is an essential concern for polyethyleneimine 25 kDa (PEI 25 kDa), a widely reported, highly effective transfection agent used in gene...
Advanced Basic Science | Dentistry | Arthritis | Gene transfer | Cross-linking | Nanoparticle | CELLS | MATERIALS SCIENCE, BIOMATERIALS | ENGINEERING, BIOMEDICAL | POLYETHYLENIMINE | VECTOR | IN-VIVO | OSTEOARTHRITIS | EFFICIENT | CYTOTOXICITY | Genetic Therapy | Synovial Membrane - pathology | Interleukin 1 Receptor Antagonist Protein - genetics | Spectroscopy, Fourier Transform Infrared | Carbamates - chemistry | Drug Delivery Systems | Transfection | Electrophoresis, Agar Gel | Polyethyleneimine - chemistry | Cell Death | Membrane Potential, Mitochondrial | Polyethyleneimine - chemical synthesis | Cross-Linking Reagents - chemistry | Magnetic Resonance Spectroscopy | Arthritis - pathology | Cells, Cultured | Rats | Plasmids - metabolism | Rats, Sprague-Dawley | Microscopy, Confocal | Carbamates - chemical synthesis | Animals | Interleukin 1 Receptor Antagonist Protein - therapeutic use | Intracellular Space - metabolism | Arthritis - therapy
Advanced Basic Science | Dentistry | Arthritis | Gene transfer | Cross-linking | Nanoparticle | CELLS | MATERIALS SCIENCE, BIOMATERIALS | ENGINEERING, BIOMEDICAL | POLYETHYLENIMINE | VECTOR | IN-VIVO | OSTEOARTHRITIS | EFFICIENT | CYTOTOXICITY | Genetic Therapy | Synovial Membrane - pathology | Interleukin 1 Receptor Antagonist Protein - genetics | Spectroscopy, Fourier Transform Infrared | Carbamates - chemistry | Drug Delivery Systems | Transfection | Electrophoresis, Agar Gel | Polyethyleneimine - chemistry | Cell Death | Membrane Potential, Mitochondrial | Polyethyleneimine - chemical synthesis | Cross-Linking Reagents - chemistry | Magnetic Resonance Spectroscopy | Arthritis - pathology | Cells, Cultured | Rats | Plasmids - metabolism | Rats, Sprague-Dawley | Microscopy, Confocal | Carbamates - chemical synthesis | Animals | Interleukin 1 Receptor Antagonist Protein - therapeutic use | Intracellular Space - metabolism | Arthritis - therapy
Journal Article
Journal of Rheumatology, ISSN 0315-162X, 04/2010, Volume 37, Issue 4, pp. 692 - 703
Objective. To assess safety and clinical outcomes in patients with inflammatory arthritis after intraarticular (IA) injection of rAAV2-TNFR:Fc, a recombinant...
Clinical trials | Biological therapy | Tumor necrosis factor inhibitors | Rheumatoid arthritis | Psoriatic arthritis | RHEUMATOID-ARTHRITIS | HISTOPLASMOSIS | TUMOR NECROSIS FACTOR INHIBITORS | SHOULDER | CLINICAL TRIALS | CONSENSUS | HAND QUESTIONNAIRE | ANKYLOSING-SPONDYLITIS | RHEUMATOLOGY | THERAPY | RHEUMATOID ARTHRITIS | ETANERCEPT | INFLIXIMAB | PSORIATIC ARTHRITIS | MONOARTHRITIS | BIOLOGICAL THERAPY | Adenoviridae | Humans | Tumor Necrosis Factor-alpha - genetics | Antirheumatic Agents - immunology | Male | Patient Selection | Receptors, Tumor Necrosis Factor - therapeutic use | Dose-Response Relationship, Drug | Immunoglobulin G - immunology | Antirheumatic Agents - adverse effects | Arthritis - immunology | Adult | Female | Receptors, Tumor Necrosis Factor - genetics | Double-Blind Method | Enzyme-Linked Immunosorbent Assay | Treatment Outcome | Immunoglobulin G - adverse effects | Immunoglobulin G - genetics | Injections, Intra-Articular | Arthritis - therapy | Genetic Vectors | Receptors, Tumor Necrosis Factor - immunology | Immunity, Cellular | Tumor Necrosis Factor-alpha - antagonists & inhibitors | Genetic Therapy - adverse effects
Clinical trials | Biological therapy | Tumor necrosis factor inhibitors | Rheumatoid arthritis | Psoriatic arthritis | RHEUMATOID-ARTHRITIS | HISTOPLASMOSIS | TUMOR NECROSIS FACTOR INHIBITORS | SHOULDER | CLINICAL TRIALS | CONSENSUS | HAND QUESTIONNAIRE | ANKYLOSING-SPONDYLITIS | RHEUMATOLOGY | THERAPY | RHEUMATOID ARTHRITIS | ETANERCEPT | INFLIXIMAB | PSORIATIC ARTHRITIS | MONOARTHRITIS | BIOLOGICAL THERAPY | Adenoviridae | Humans | Tumor Necrosis Factor-alpha - genetics | Antirheumatic Agents - immunology | Male | Patient Selection | Receptors, Tumor Necrosis Factor - therapeutic use | Dose-Response Relationship, Drug | Immunoglobulin G - immunology | Antirheumatic Agents - adverse effects | Arthritis - immunology | Adult | Female | Receptors, Tumor Necrosis Factor - genetics | Double-Blind Method | Enzyme-Linked Immunosorbent Assay | Treatment Outcome | Immunoglobulin G - adverse effects | Immunoglobulin G - genetics | Injections, Intra-Articular | Arthritis - therapy | Genetic Vectors | Receptors, Tumor Necrosis Factor - immunology | Immunity, Cellular | Tumor Necrosis Factor-alpha - antagonists & inhibitors | Genetic Therapy - adverse effects
Journal Article
American Journal of Pathology, ISSN 0002-9440, 04/1999, Volume 154, Issue 4, pp. 1159 - 1169
The goal of this study was to determine the efficacy of local IL-1Ra gene therapy by intra-articular plasmid injections on structural changes in the...
RHEUMATOID-ARTHRITIS | GROWTH-FACTOR-BETA | INTRAARTICULAR INJECTIONS | SYNOVIAL-MEMBRANE | IN-VIVO | PLASMID DNA | OSTEO-ARTHRITIS | HUMAN ARTICULAR CHONDROCYTES | IL-1 RECEPTOR | PATHOLOGY | EXPRESSION | Immunohistochemistry | Gene Transfer Techniques | Genetic Therapy | Rabbits | Sialoglycoproteins - genetics | Hindlimb | Sialoglycoproteins - metabolism | Synovial Fluid - metabolism | Joints - pathology | Disease Progression | Osteoarthritis - therapy | Plasmids - therapeutic use | Sialoglycoproteins - therapeutic use | Antirheumatic Agents - metabolism | Animals | Dogs | Plasmids - genetics | Polymerase Chain Reaction | Interleukin 1 Receptor Antagonist Protein | Osteoarthritis - pathology | Receptors, Interleukin-1 - antagonists & inhibitors | Joints - metabolism | Antirheumatic Agents - therapeutic use | Regular
RHEUMATOID-ARTHRITIS | GROWTH-FACTOR-BETA | INTRAARTICULAR INJECTIONS | SYNOVIAL-MEMBRANE | IN-VIVO | PLASMID DNA | OSTEO-ARTHRITIS | HUMAN ARTICULAR CHONDROCYTES | IL-1 RECEPTOR | PATHOLOGY | EXPRESSION | Immunohistochemistry | Gene Transfer Techniques | Genetic Therapy | Rabbits | Sialoglycoproteins - genetics | Hindlimb | Sialoglycoproteins - metabolism | Synovial Fluid - metabolism | Joints - pathology | Disease Progression | Osteoarthritis - therapy | Plasmids - therapeutic use | Sialoglycoproteins - therapeutic use | Antirheumatic Agents - metabolism | Animals | Dogs | Plasmids - genetics | Polymerase Chain Reaction | Interleukin 1 Receptor Antagonist Protein | Osteoarthritis - pathology | Receptors, Interleukin-1 - antagonists & inhibitors | Joints - metabolism | Antirheumatic Agents - therapeutic use | Regular
Journal Article
Circulation, ISSN 0009-7322, 02/1999, Volume 99, Issue 7, pp. 861 - 866
Background-Cytokine gene variations are contributory factors in inflammatory pathology. Allele frequencies of interleukin (IL)-1 cluster genes [IL-1A(-889),...
Interleukins | Coronary artery disease | Genes | coronary artery disease | CARDIAC & CARDIOVASCULAR SYSTEMS | genes | RISK | interleukins | HEART-DISEASE | MEN | PERIPHERAL VASCULAR DISEASE | VASCULAR ENDOTHELIAL-CELLS | HEMATOLOGY | ASSOCIATION | EXPRESSION | SEVERITY | FIBRINOGEN
Interleukins | Coronary artery disease | Genes | coronary artery disease | CARDIAC & CARDIOVASCULAR SYSTEMS | genes | RISK | interleukins | HEART-DISEASE | MEN | PERIPHERAL VASCULAR DISEASE | VASCULAR ENDOTHELIAL-CELLS | HEMATOLOGY | ASSOCIATION | EXPRESSION | SEVERITY | FIBRINOGEN
Journal Article
Annals of the Rheumatic Diseases, ISSN 0003-4967, 05/2010, Volume 69, Issue 5, pp. 856 - 861
Background A lack of biomarkers that identify patients at risk for severe osteoarthritis (OA) complicates development of disease-modifying OA drugs. Objective...
POLYMORPHISMS | INFLAMMATION | CANDIDATE GENES | HAPLOTYPE | RHEUMATOLOGY | ARTHRITIS | SUPPRESSION | ASSOCIATION | EXPRESSION | IL-10 | PROGRESSION | Haplotypes | Severity of Illness Index | Genetic Predisposition to Disease | Humans | Middle Aged | Genotype | Interleukin 1 Receptor Antagonist Protein - genetics | Male | Genetic Markers | Synovial Fluid - chemistry | Osteoarthritis, Knee - diagnostic imaging | Aging - pathology | Radiography | Aging - genetics | Inflammation Mediators - analysis | Osteoarthritis, Knee - genetics | Adult | Female | Aged | Polymorphism, Single Nucleotide | Osteoarthritis, Knee - metabolism | Interleukin-1 | Genetic markers | Genetic aspects | Research | Osteoarthritis | Risk factors | Genetic polymorphisms | Immunoassay | Disease | Cytokines | Laboratories | Genes | ISO standards | Arthritis | Joint surgery | Patients | Biological activity | Proteins | Studies | Body mass index | Genotype & phenotype | Hospitals | Genetics | Age | Chronic illnesses
POLYMORPHISMS | INFLAMMATION | CANDIDATE GENES | HAPLOTYPE | RHEUMATOLOGY | ARTHRITIS | SUPPRESSION | ASSOCIATION | EXPRESSION | IL-10 | PROGRESSION | Haplotypes | Severity of Illness Index | Genetic Predisposition to Disease | Humans | Middle Aged | Genotype | Interleukin 1 Receptor Antagonist Protein - genetics | Male | Genetic Markers | Synovial Fluid - chemistry | Osteoarthritis, Knee - diagnostic imaging | Aging - pathology | Radiography | Aging - genetics | Inflammation Mediators - analysis | Osteoarthritis, Knee - genetics | Adult | Female | Aged | Polymorphism, Single Nucleotide | Osteoarthritis, Knee - metabolism | Interleukin-1 | Genetic markers | Genetic aspects | Research | Osteoarthritis | Risk factors | Genetic polymorphisms | Immunoassay | Disease | Cytokines | Laboratories | Genes | ISO standards | Arthritis | Joint surgery | Patients | Biological activity | Proteins | Studies | Body mass index | Genotype & phenotype | Hospitals | Genetics | Age | Chronic illnesses
Journal Article
Arteriosclerosis, Thrombosis, and Vascular Biology, ISSN 1079-5642, 07/2008, Volume 28, Issue 7, pp. 1407 - 1412
BACKGROUND—Circulating levels of acute phase reactant proteins such as plasma C-reactive protein (CRP) are likely influenced by multiple genes regulating the...
Inflammation | C-reactive protein | IL-1 receptor antagonist | Fibrinogen | ACUTE-PHASE PROTEIN | IL-1RA | fibrinogen | INTERLEUKIN-1 RECEPTOR ANTAGONIST | SERUM-AMYLOID-A | COMBINATIONS | inflammation | CARDIOVASCULAR-DISEASE | PERIPHERAL VASCULAR DISEASE | CORONARY-HEART-DISEASE | PROMOTER | HEMATOLOGY | EXPRESSION | Haplotypes | Prospective Studies | United States | Humans | Middle Aged | Interleukin 1 Receptor Antagonist Protein - genetics | Male | Case-Control Studies | Inflammation - blood | Interleukin 1 Receptor Antagonist Protein - blood | C-Reactive Protein - metabolism | Aged, 80 and over | Adult | Female | Genetic Predisposition to Disease | Reproducibility of Results | Gene Frequency | Risk Factors | Inflammation Mediators - blood | Biomarkers - blood | Linkage Disequilibrium | Phenotype | Inflammation - genetics | Aged | Polymorphism, Single Nucleotide | IL-1receptor antagonist
Inflammation | C-reactive protein | IL-1 receptor antagonist | Fibrinogen | ACUTE-PHASE PROTEIN | IL-1RA | fibrinogen | INTERLEUKIN-1 RECEPTOR ANTAGONIST | SERUM-AMYLOID-A | COMBINATIONS | inflammation | CARDIOVASCULAR-DISEASE | PERIPHERAL VASCULAR DISEASE | CORONARY-HEART-DISEASE | PROMOTER | HEMATOLOGY | EXPRESSION | Haplotypes | Prospective Studies | United States | Humans | Middle Aged | Interleukin 1 Receptor Antagonist Protein - genetics | Male | Case-Control Studies | Inflammation - blood | Interleukin 1 Receptor Antagonist Protein - blood | C-Reactive Protein - metabolism | Aged, 80 and over | Adult | Female | Genetic Predisposition to Disease | Reproducibility of Results | Gene Frequency | Risk Factors | Inflammation Mediators - blood | Biomarkers - blood | Linkage Disequilibrium | Phenotype | Inflammation - genetics | Aged | Polymorphism, Single Nucleotide | IL-1receptor antagonist
Journal Article
Gene Therapy, ISSN 0969-7128, 2002, Volume 9, Issue 1, pp. 12 - 20
Osteoarthritis in horses and in humans is a significant social and economic problem and continued research and improvements in therapy are needed. Because...
In vivo | Equine | Gene therapy | Osteoarthritis | Interleukin-1 receptor antagonist | interleukin 1 receptor antagonist | interleukin 1 receptors
In vivo | Equine | Gene therapy | Osteoarthritis | Interleukin-1 receptor antagonist | interleukin 1 receptor antagonist | interleukin 1 receptors
Journal Article
Anesthesiology, ISSN 0003-3022, 2011, Volume 114, Issue 5, pp. 1162 - 1168
Background: The interleukin-1 receptor antagonist (IL-1Ra) is the principal determinant of IL-1 beta bioactivity within the IL-1 gene cluster, regulating IL-1...
CYTOKINE PRODUCTION | PAIN | IL-1RA | ANESTHESIOLOGY | IL-1-BETA | TANDEM REPEAT | INTRON-2 | ANALGESIA | Follow-Up Studies | Pain, Postoperative - drug therapy | Humans | Middle Aged | Postoperative Period | Analgesics, Opioid - therapeutic use | Interleukin 1 Receptor Antagonist Protein - genetics | Male | Interleukin 1 Receptor Antagonist Protein - blood | Nephrectomy | Pain, Postoperative - genetics | Analgesics, Opioid - administration & dosage | Polymerase Chain Reaction | Female | Polymorphism, Genetic - genetics | Pain Measurement | Morphine - administration & dosage | Morphine - therapeutic use
CYTOKINE PRODUCTION | PAIN | IL-1RA | ANESTHESIOLOGY | IL-1-BETA | TANDEM REPEAT | INTRON-2 | ANALGESIA | Follow-Up Studies | Pain, Postoperative - drug therapy | Humans | Middle Aged | Postoperative Period | Analgesics, Opioid - therapeutic use | Interleukin 1 Receptor Antagonist Protein - genetics | Male | Interleukin 1 Receptor Antagonist Protein - blood | Nephrectomy | Pain, Postoperative - genetics | Analgesics, Opioid - administration & dosage | Polymerase Chain Reaction | Female | Polymorphism, Genetic - genetics | Pain Measurement | Morphine - administration & dosage | Morphine - therapeutic use
Journal Article